Abstract:Patients with 22q11.2 microduplication syndrome exhibit a high degree of phenotypic heterogeneity and incomplete penetrance, making prenatal diagnosis challenging due to phenotypic variability. This retrospective study aimed to clarify ultrasound features and maternal characteristics associated with 22q11.2 microduplication in Chinese fetuses. Primary prenatal ultrasound features of affected fetuses include variable cardiac and cardiovascular anomalies, increased nuchal translucency (≥3 mm), renal abnormalities, and polyhydramnios. More than half of fetuses considered showed no intrauterine manifestations; therefore, prenatal diagnostic indicators were primarily advanced maternal age or high‐risk Down syndrome screening. Most fetuses had microduplications in proximal or central 22q11.2 regions, with only three cases with distal microduplications. Among parents of fetuses considered, 87% (27/31) continued the pregnancy. During follow‐up, 19 cases remained clinically asymptomatic. Nonspecific 22q11.2 microduplication features in fetuses and its mild postnatal disease presentation highlight the need to cautiously approach prenatal diagnosis and pregnancy decision‐making. Background Patients with 22q11.2 microduplication syndrome exhibit a high degree of phenotypic heterogeneity and incomplete penetrance, making prenatal diagnosis challenging due to phenotypic variability. This report aims to raise awareness among prenatal diagnostic practitioners regarding the variant's complexity, providing a basis for prenatal genetic counseling. Methods Family and clinical data of 31 fetuses with 22q11.2 microduplications confirmed by chromosomal microarray between June 2017 and June 2023 were considered. Results Primary prenatal ultrasound features of affected fetuses include variable cardiac and cardiovascular anomalies, increased nuchal translucency (≥3 mm), renal abnormalities, and polyhydramnios. More than half of fetuses considered showed no intrauterine manifestations; therefore, prenatal diagnostic indicators were primarily advanced maternal age or high‐risk Down syndrome screening. Most fetuses had microduplications in proximal or central 22q11.2 regions, with only three cases with distal microduplications. Among parents of fetuses considered, 87% (27/31) continued the pregnancy. During follow‐up, 19 cases remained clinically asymptomatic. Conclusion Nonspecific 22q11.2 microduplication features in fetuses and its mild postnatal disease presentation highlight the need to cautiously approach prenatal diagnosis and pregnancy decision‐making. Increased clinical efforts should be made regarding providing parents with specialized genetic counseling, long‐term follow‐up, and fetal risk information.

Experience in prenatal ultrasound diagnosis of fetal microtia and associated abnormalities

Predicting the Risk of Microtia From Prenatal Factors: A Hospital-Based Case-Control Study

Prenatal Diagnosis of Microdeletions or Microduplications in the Proximal, Central, and Distal Regions of Chromosome 22q11.2: Ultrasound Findings and Pregnancy Outcome.

The Role of MRI in the Prenatal Diagnosis and Classification of Fetal Microtia

Chromosomal Microarray Analysis in Fetuses with Ultrasound Abnormalities

Clinical Experience of Prenatal Chromosomal Microarray Analysis in 6159 Ultrasonically Abnormal Fetuses

Prenatal ultrasound phenotypic and genetic etiology of the 17q12 microduplication syndrome

Epidemiological Analysis of Microtia: A Retrospective Study in 345 Patients in China

Prenatal diagnosis of the recurrent 1q21.1 microdeletions in fetuses with ultrasound anomalies and review of the literature

Prenatal diagnosis and genetic study of 22q11.2 microduplication in Chinese fetuses: A series of 31 cases and literature review

[Single Nucleotide Polymorphism Microarray in Prenatal Diagnosis of Fetuses with Absent Nasal Bone].

Prenatal Diagnosis of Fetal Micrognathia at 11–20 Weeks of Gestation: A Prospective Observation Study

Prenatal phenotypic analysis and genetic counseling for 22q11.21 microdeletion and microduplication syndrome

The significance of ultrasound in prenatal diagnosis of chromosome abnormality

Prenatal ultrasound diagnosis of congenital heart disease associated with extracardiac anomaly

Genetic Screening of Targeted Region on the Chromosome 22q11.2 in Patients with Microtia and Congenital Heart Defect

Comparison of Chromosomal Microarray Analysis and Noninvasive Prenatal Testing in Pregnant Women with Fetal Ultrasonic Soft Markers

Electrocardiographic abnormalities in patients with microtia

Prenatal diagnosis and postnatal follow-up of 15 fetuses with 16p13.11 microduplication syndrome

Prenatal diagnosis of a de novo 15q11.2 microdeletion in a maternal inv(4)(p15q31) fetus with increased nuchal translucency: A case report and literature review.

Prenatal Ultrasound Assessment for Fetal Structural Abnormalities